Hypermethylation-repressed methionine adenosyltransferase 1A as a potential biomarker for hepatocellular carcinoma

Hepatology Research

Volumn 43, Issue 4, 2013, Pages 374-383

  Zhang, Jin ^a   Gong, Chen ^a   Bing, Yuntao ^a   Li, Ting ^a   Liu, Zhisu ^a   Liu, Quanyan ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; MAT1A; Methylation

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN; METHIONINE ADENOSYLTRANSFERASE; METHIONINE ADENOSYLTRANSFERASE 1A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CPG ISLAND; DISEASE MARKER; DNA METHYLATION; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 84876102073     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01099.x     Document Type: Article

References (25)

1. Huang S, He X. The role of microRNAs in liver cancer progression. Br J Cancer 2011; 104: 235-240.
2. Villanueva A, Llovet JM. Targeted therapies for hepatocellular carcinoma. Gastroenterology 2011; 140: 1410-1426.
3. Greenwald P. A favorable view: progress in cancer prevention and screening. Recent Results Cancer Res 2007; 174: 3-17.
4. Park S, Bae J, Nam BH etal. Aetiology of cancer in Asia. Asian Pac J Cancer Prev 2008; 9: 371-380.
5. Nishida N, Goel A. Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review. Curr Genomics 2011; 12: 130-137.
6. Nephew KP, Huang TH. Epigenetic gene silencing in cancer initiation and progression. Cancer Lett 2003; 190: 125-133.
7. Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 2011; 11: 726-734.
8. Huang J. Current progress in epigenetic research for hepatocarcinomagenesis. Sci China C Life Sci 2009; 52: 31-42.
9. Lu SC, Mato JM. S-Adenosylmethionine in cell growth, apoptosis and liver cancer. J Gastroenterol Hepatol 2008; 23 (Suppl 1): S73-77.
10. Cai J, Sun WM, Hwang JJ etal. Changes in S-adenosylmethionine synthetase in human liver cancer: molecular characterization and significance. Hepatology 1996; 24: 1090-1097.
11. Avila MA, Berasain C, Torres L etal. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol 2000; 33: 907-914.
12. Li J, Ramani K, Sun Z etal. Forced expression of methionine adenosyltransferase 1A in human hepatoma cells suppresses in vivo tumorigenicity in mice. Am J Pathol 2010; 176: 2456-2466.
13. Lu SC, Alvarez L, Huang ZZ etal. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci U S A 2001; 98: 5560-5565.
14. Tomasi ML, Iglesias-Ara A, Yang H etal. S-adenosylmethionine regulates apurinic/apyrimidinic endonuclease 1 stability: implication in hepatocarcinogenesis. Gastroenterology 2009; 136: 1025-1036.
15. Ko KS, Tomasi ML, Iglesias-Ara A etal. Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice. Hepatology 2010; 52: 2096-2108.
16. Torres L, Avila MA, Carretero MV etal. Liver-specific methionine adenosyltransferase MAT1A gene expression is associated with a specific pattern of promoter methylation and histone acetylation: implications for MAT1A silencing during transformation. FASEB J 2000; 14: 95-102.
17. Mato JM, Alvarez L, Ortiz P etal. S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol Ther 1997; 73: 265-280.
18. Garcia-Trevijano ER, Latasa MU, Carretero MV etal. S-adenosylmethionine regulates MAT1A and MAT2A gene expression in cultured rat hepatocytes: a new role for S-adenosylmethionine in the maintenance of the differentiated status of the liver. FASEB J 2000; 14: 2511-2518.
19. Huang ZZ, Mao Z, Cai J etal. Changes in methionine adenosyltransferase during liver regeneration in the rat. Am J Physiol 1998; 275: G14-21.
20. Cai J, Mao Z, Hwang JJ etal. Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells. Cancer Res 1998; 58: 1444-1450.
21. Frau M, Tomasi ML, Simile MM etal. Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression. Hepatology 2012; 56 (1): 165-175.
22. Tomasi ML, Li TW, Li M etal. Inhibition of human methionine adenosyltransferase 1A transcription by coding region methylation. J Cell Physiol 2012; 227: 1583-1591.
23. Liu Q, Chen J, Liu L etal. The X protein of hepatitis B virus inhibits apoptosis in hepatoma cells through enhancing the methionine adenosyltransferase 2A gene expression and reducing S-adenosylmethionine production. J Biol Chem 2011; 286: 17168-17180.
24. Mato JM, Corrales FJ, Lu SC etal. S-Adenosylmethionine: a control switch that regulates liver function. FASEB J 2002; 16: 15-26.
25. Vazquez-Chantada M, Fernandez-Ramos D, Embade N etal. HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis. Gastroenterology 2010; 138: 1943-1953.